Archives

Shields Health Solutions and Sutter Health Expand Collaboration to Enhance Patient Access to Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and Sutter Health Expand Collaboration to Enhance Patient Access to Specialty Pharmacy Services

STOUGHTON, Mass. & SACRAMENTO, Calif.—(BUSINESS WIRE)—Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the United States and a Walgreens-owned company, has expanded its work with Sutter Health, one…

Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population

This poster explores the impact of the pharmacy liaison-managed care model at CHRISTUS Health System on HbA1c reduction and medication adherence for patients living with diabetes with baseline A1C>9.

Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services
Shields and UnityPoint at Home have expanded their partnership providing patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, broaden treatment options, enhance medication management, and improve overall health.
Hep-C Outcomes 2023 216 115 Shields Health Solutions

Hep-C Outcomes 2023

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

RA Outcomes 2023 216 115 Shields Health Solutions

RA Outcomes 2023

RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.

MS Outcomes 2023 216 115 Shields Health Solutions

MS Outcomes 2023

MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body

HIV Outcomes 2023

HIV Outcomes 2023 216 115 Shields Health Solutions

Human immunodeficiency virus (HIV) is a virus spread through contact with certain fluids of an infected person, attacking the immune system and affecting the body's ability to fight infections and certain cancers. HIV is incurable and can progress to the most advanced disease stage if left untreated, known as Acquired Immunodeficiency Syndrome (AIDS).

https://shieldshealthsolutions.com/content/uploads/2024/07/Shields_HIV_Sheet_2024_Final.pdf#new_tab
Oncology Outcomes 2023 1024 1024 Shields Health Solutions

Oncology Outcomes 2023

Cancer, a genetic disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body, is caused by changes to genes that control the…

Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Process 216 115 Shields Health Solutions

Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Process

This poster presents an evaluation of a social determinants of health screening and intervention framework within an integrated health system specialty pharmacy care model using a closed-loop referral process.